Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Agilent Technologies' trading volume on February 26 was $722 million, an increase of 134.54% compared to the previous trading day.
On February 26, 2026, Agilent Technologies (A), a life sciences tools and services company, had a trading volume of $722 million, ranking 184th among U.S. stocks that day. The trading volume increased by 134.54% compared to the previous day, with a total of 6.0954 million shares traded.
On February 26, 2026, Agilent Technologies (A) fell 3.01%, closing at $120.97. The stock declined by 4.25% over the past five trading days, 9.62% for the entire month of February, 11.10% since the beginning of the year, and 10.04% over the past 52 weeks.
*If the company has been listed for less than 52 weeks, the 52-week change is calculated from the listing date to the present (this also applies to companies listed for less than 1 month or fewer than 5 trading days).
Agilent Technologies released its Q1 FY2026 earnings report on February 25, 2026. Revenue for the period from November 1, 2025, to January 31, 2026, was $1.798 billion, a 6.96% increase year-over-year. Net profit was $305 million, down 4.09% year-over-year.
On February 26, 2026, Barclays maintained an “Overweight” rating on Agilent Technologies with a target price of $150.
Agilent Technologies was incorporated in Delaware in May 1999. It is a global leader in the life sciences, diagnostics, and applied markets, providing application-centric solutions across the entire laboratory workflow, including instruments, software, services, and consumables.